Position
Chief Financial Officer
Company
Aktis Oncology
BostonBiotechnologyHealth CareTherapeuticsDescription
Aktis Oncology, Inc. has appointed Mr Kyle Kuvalanka as its Chief Financial Officer. With over 20 years of experience in biopharmaceutical leadership, his expertise will advance Aktis' financial and corporate development efforts.
Quick answer
Aktis Oncology Appoints Kyle Kuvalanka as Chief Financial Officer (November 5, 2025). Aktis Oncology is based in Boston, Massachusetts, United States.
- Who is the new Chief Financial Officer at Aktis Oncology?
- Aktis Oncology named Kyle Kuvalanka Chief Financial Officer, announced November 5, 2025.
- What did Aktis Oncology announce on November 5, 2025?
- Aktis Oncology, Inc. has appointed Mr Kyle Kuvalanka as its Chief Financial Officer. With over 20 years of experience in biopharmaceutical leadership, his expertise will advance Aktis' financial and corporate development efforts.
- What does Aktis Oncology do?
- Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.
- Where is Aktis Oncology based?
- Aktis Oncology is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Esperion Therapeutics (November 4, 2025), Ratio Therapeutics (November 4, 2025), Syndeio Biosciences (November 4, 2025) and Vor Bio (November 3, 2025) also announced leadership changes within 45 days of Aktis Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Esperion Appoints John Harlow as Chief Commercial Officer (November 4, 2025)
- Ratio Therapeutics Appoints Marcel Reichen as Chief Strategy Officer (November 4, 2025)
- Syndeio Biosciences Appoints Aaron Koenig, M.D., as Chief Medical Officer (November 4, 2025)
- Vor Biopharma Appoints Dr. Jeremy Sokolove as Chief Medical Officer (November 3, 2025)
- Prime Medicine Appoints Matthew Hawryluk as Chief Business Officer (November 3, 2025)
- Kalaris Therapeutics Appoints Matthew Gall as Chief Financial Officer (November 3, 2025)
Who to call at Aktis Oncology, and when
A new leader at Aktis Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Aktis Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aktis Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aktis Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aktis Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aktis Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.